Navigation Links
MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties
Date:11/30/2009

MT. LAUREL, N.J., Nov. 30 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of technology-enabled clinical documentation services, today announced that it has signed an agreement with Nuance Communications, Inc. (Nuance) under which MedQuist will now license Nuance's SpeechMagic speech recognition engine and processing software for use in SpeechQ of General Medicine(TM), MedQuist's front-end speech recognition application for all medical disciplines. SpeechMagic currently powers MedQuist's SpeechQ for Radiology(TM) application, used by thousands of radiologists to streamline the documentation process. SpeechQ eliminates, in most cases, the vast majority of transcription costs while reducing report turnaround time and time spent documenting so that the physician can focus on patient care.

Based on its strong success in radiology and increasing customer demand for real-time interactive speech recognition in many other hospital departments, MedQuist is launching a SpeechQ for General Medicine solution. This software application enables physicians in high-volume dictation specialties such as orthopedics, cardiology, surgery, and many others to realize the benefits of this technology. In addition, within an acute care setting, many report types such as Progress Notes, History & Physicals, Procedure Notes, and Consultations lend themselves to interactive real-time speech recognition workflow. In real-time speech recognition, physicians dictate and self-complete reports in one sequence, bypassing the transcription process. The results include dramatic reductions in cost and turnaround time, while preserving physician preference for detailed narrative documentation.

"Our current and prospective customers have been pressing us for real-time speech solutions outside of radiology, and we are pleased to be positioned now to satisfy that demand," said Peter Masanotti, CEO of MedQuist. "This step is essential to our strategy of offering a full spectrum of cost-saving options for healthcare organizations and putting MedQuist at the forefront of providing easy-to-use solutions assisting physician adoption of their EHRs. That ultimately contributes to improved patient care."

About MedQuist

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE MedQuist Inc.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention
2. MedQuist Announces Reseller Agreement With Clario
3. US Trauma Fixation Device Market Not Seeing Signs of Slowdown
4. WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump
5. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
6. Ionian Technologies, Inc. Signs Molecular Diagnostic Manufacturing Agreement With Roche Diagnostics
7. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
8. Sosei Signs Definitive Distribution Agreement With ASKA for Commercialisation of SOH-075 (NorLevo(R))
9. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
10. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
11. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Homozygous Familial Hypercholesterolemia (HoFH) - ... Global Markets Direct,s latest Pharmaceutical and Healthcare ... – Pipeline Review, H2 2016, provides an ... (Metabolic Disorders) pipeline landscape. Homozygous familial ... caused due to mutation from both parents. ...
(Date:12/6/2016)... The pen needles market is projected to reach USD ... 2016, growing at a CAGR of 11.2% during the ... years, the pen needles market has witnessed various technological ... for safety injections in the healthcare industry. These advancements ... with an aim to reduce pain, increase comfort, and ...
(Date:12/6/2016)... 2016   AlloSource , one of the ... and soft-tissue allografts for use in surgical procedures, ... for being named to the Board of Examiners ... by the Commerce Department,s National Institute of Standards ... process excellence. The Baldrige Award is the nation,s ...
Breaking Medicine Technology:
(Date:12/7/2016)... Arizona (PRWEB) , ... December 07, 2016 , ... Delete® ... Just in Time For The Holiday Party Season. Save Up To 33% Off Botox® ... Laser Salon is providing the Phoenix Valley with Delightful Deals on Botox® ...
(Date:12/7/2016)... ... , ... The medical profession is well aware that heart attacks do indeed ... heart attacks among 138,602 people recorded a 35% higher number of heart attacks in ... of course–no time of year is a good time for a heart attack! In ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... medicine device WellnessPro Plus for consumers and healthcare professionals to manage chronic ... by expanding the treatment modalities available in a single device. The announcement ...
(Date:12/7/2016)... ... 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief but ... presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of published ... for this country. , Nancy attributes her patriotic nature to her WWII veteran father. ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... individuals impacted by cerebral cavernous angiomas, was awarded a grant from the Julian ... engagement program. New Mexico has more people with cavernous angioma than anywhere in ...
Breaking Medicine News(10 mins):